IRONWOOD PHARMACEUTICALS INC (IRWD) Corporate Subsidiaries
IRONWOOD PHARMACEUTICALS INC (IRWD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IRWD
CIK: 1446847
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMark Valentine
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-12 | FORM 8-K | 0001104659-26-116423 | View SEC Doc Filr Page |
| 144 | 2026-09-23 | — | 144 Filing | 0001808509-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 | 0001193125-26-394323 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003597 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000487 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001104659-26-091987 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001104659-26-091625 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-28 | — | SCHEDULE 13G/A Filing | 0002012383-26-002534 | View SEC Doc Filr Page |
| 4 | 2026-07-22 | 2026-07-20 | 4 | 0001193125-26-312410 | View SEC Doc Filr Page |
| 3 | 2026-07-22 | 2026-07-20 | 3 | 0001193125-26-312388 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-07 | 4 | 0001193125-26-299749 | View SEC Doc Filr Page |
| 144 | 2026-07-07 | — | 144 Filing | 0001950047-26-006947 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-16 | FORM 8-K | 0001104659-26-075730 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 | 0001193125-26-274301 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 | 0001193125-26-274292 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 | 0001193125-26-274288 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 | 0001193125-26-274283 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 | 0001193125-26-274279 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 | 0001193125-26-274275 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 | 0001193125-26-274256 | View SEC Doc Filr Page |
| 144 | 2026-06-16 | — | 144 Filing | 0001950047-26-006206 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-15 | FORM 8-K | 0001104659-26-074023 | View SEC Doc Filr Page |
| 8-K/A | 2026-05-21 | 2026-05-08 | FORM 8-K/A | 0001104659-26-065140 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 | 0001193125-26-234397 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-26-002161 | View SEC Doc Filr Page |